Skip to content

Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults

Intensive Diet and Exercise for Arthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00381290
Enrollment
454
Registered
2006-09-27
Start date
2006-10-31
Completion date
2011-06-30
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Arthritis, Arthritis, Degenerative, Knee Health, Obesity, Overweight, Osteoarthritis, Weight Loss, Diet, Exercise, Knee Pain

Brief summary

The purpose of this study is to compare the effects of a calorie-restricting diet, exercise, and a combination of both in reducing knee inflammation and compressive forces in obese and overweight adults with knee osteoarthritis (OA).

Detailed description

OA, the most common form of arthritis, occurs in about 21 million Americans. Of all the weight-bearing joints, the knee is most commonly affected by OA. Knee OA leads to physical changes to the entire joint structure, including cartilage, neighboring bone, and ligaments. Such structural changes to the knee alter joint function during movement, resulting in pain. The pain typically leads to less physical activity, leading to weight gain, followed by impaired physical function and disability. Excessive body weight adds to the compressive forces on the knee joint and is a risk factor for OA. While there is no cure for OA, weight loss is the best nonpharmacologic way to slow OA progression. The amount of weight loss necessary to alter OA progression is unknown. The purpose of this study is to compare the effects of significant dietary restriction, exercise, and a combination of both in reducing knee inflammation and compressive forces in obese and overweight adults with knee OA. The study will also examine how diet and exercise affect everyday function and pain levels, as well as the extent of weight loss necessary for slowing OA disease progression. This study will last 18 months. Four, 2-hour screening visits will include various questionnaires, physical exams, physical performance tests, x-rays, and blood and urine collection. Half of the participants will also undergo additional x-rays, magnetic resonance imaging (MRI), and a CT scan. Eligible participants will be randomly assigned to one of three intervention groups: * Group 1 participants will follow a calorie-restricted diet * Group 2 participants will follow an exercise regimen * Group 3 participants will follow a calorie-restricted diet and an exercise regimen Group 1 and 3 participants will aim to lose at least 10% of their body weight and drop to the next lower body mass index (BMI) class level; Group 2 participants will aim to maintain their weight. Group 1 and 3 participants will follow the prescribed diet, which will include traditional healthy food and up to two meal replacement supplements. Initially, the diet will be set to result in an overall loss of 800 to 1000 calories per day. Body weight will be monitored during weekly nutritional education and behavioral sessions. For the first 6 months, Group 1 and 3 participants will attend one individual session and three group sessions per month. During Months 7 through 18, participants will attend group sessions once every two weeks and individual sessions once every 3 months. Throughout the study, participants will record food and beverage intake in daily logs that will be collected monthly. Group 2 and 3 participants will partake in three, 60-minute exercise sessions per week for the duration of the study. The exercise sessions will incorporate aerobic exercise and resistance training. Participants will also be encouraged to exercise at home. Body weight will be monitored monthly. Follow-up evaluations for all participants will occur at Months 6 and 18, during which most of the screening procedures will be repeated. The Month 6 follow-up will include two study visits, and the Month 18 follow-up will include three study visits. Group 2 participants will be offered dietary counseling at the end of the study.

Interventions

BEHAVIORALDiet

The prescribed diet will include traditional healthy food and up to two meal replacement supplements. Initially, the diet will be set to result in an overall loss of 800 to 1000 calories per day.

BEHAVIORALExercise

The program will consist of 60-minute exercise sessions per week for the duration of the study. The exercise sessions will incorporate aerobic exercise and resistance training. Participants will also be encouraged to exercise at home.

Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
CollaboratorNIH
General Nutrition Center, Inc
CollaboratorINDUSTRY
Wake Forest University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Grade II to III radiographic tibiofemoral OA of one or both knees * Body mass index (BMI) of 27 to 37 * Sedentary lifestyle, defined as not participating in more than 30 minutes of formal exercise per week within the 6 months prior to study entry

Exclusion criteria

* Significant comorbidity that may pose a safety risk to the participant or otherwise interfere with the study. More information about this criterion can be found in the protocol. * Previous acute knee injury * Knee injection within 1 month of study entry * Knee surgery within 6 months of study entry * Knee OA other than tibiofemoral OA * Unwilling or unable to change eating and physical activity habits due to environment * Cannot speak or read English * Excess alcohol use (21 or more drinks per week) * Unable to finish the 18-month study or unlikely to comply with the study * Unable to undergo MRI of the knee * Significant cognitive impairment

Design outcomes

Primary

MeasureTime frame
Inflammatory biomarkersMeasured at 0, 6, and 18 months (analyzed at 18 months)
Knee joint loadsMeasured at 0, 6, and 18 months

Secondary

MeasureTime frame
FunctionMeasured at 0, 6, and 18 months
PainMeasured at 0, 6, and 18 months
Bone marrow lesionsMeasured at 0 and 18 months (analyzed at 18 months)
Change in quadriceps' strength and disease progression as a function of knee alignmentMeasured at 0, 6, and 18 months (analyzed at 18 months)
MobilityMeasured at 0, 6, and 18 months
Articular cartilageMeasured at 0 and 18 months (analyzed at 18 months)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026